← Evidence map

TrialRespiratory research2022

Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.

Abdullah Sakkat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35264154